Michael Berman

Dr. Michael Berman is a member of Pathfinder International's Board of Directors and President and CEO of the Michael A. Berman Group, Inc., a healthcare consulting firm.

He is also a consultant for Stockcamp & Associates and McKinsey & Company, and previously to the Dean of the Yale School of Medicine. Dr. Berman serves as Chairman of the Board for US Invest Group and has served as the interim CEO of the Yale Medical Group.

For eight years, Dr. Berman was with New York Presbyterian Hospital, serving first as Senior Vice President and Chief Medical Officer and later Executive Vice President and Director, heading the merger of the New York Hospital and the Presbyterian Hospital of New York. 

Prior to this he was with the University of Maryland for 21 years where he established the Division of Pediatric Cardiology, served as Professor and Chairman of the Department of Pediatrics at the University of Maryland School Of Medicine, and created Maryland's Hospital for Children. Additionally, he has held teaching appointments at Yale University School of Medicine, Columbia University College of Physicians and Surgeons, and Cornell University. 

In 1973 Dr. Berman developed the Berman Balloon Angiographic Catheter which is still the standard catheter for infants and children’s heart catheterizations worldwide. 

Dr. Berman holds an MD from the State University of New York, Syracuse. He has published and lectured extensively on Pediatrics, Pediatric Cardiology and Hospital & Physician Management, Efficiency & Strategy issues. Dr. Berman has received awards and recognition from the American Heart Association's Maryland Chapter, the Children's Cancer Foundation, and the Society of Pediatric Research. He is a Fellow of both the American College of Cardiology and the American Academy of Pediatrics.

Scroll to top